Skip to main content
Back
Watch Compare

Korro Bio, Inc.

Data quality: 100%
KRRO
Nasdaq Manufacturing Chemicals
$13.33
▼ $0.14 (-1.00%)
Mkt Cap: 192.18 M
Price
$13.33
Mkt Cap
192.18 M
Day Range
$13.00 — $13.50
52-Week Range
$5.20 — $55.89
Volume
53,325
Open $13.20
50D / 200D Avg
$11.75
13.41% above
50D / 200D Avg
$18.63
28.48% below

Quick Summary

Key Takeaways

Revenue declined -17.90% annually over 5 years
Negative free cash flow of -79.08 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 199.36%
Capital efficient — spends only 8.10% of revenue on capex

Growth

Revenue Growth (5Y)
-17.90%
Below sector avg (9.35%)
Revenue (1Y)181.46%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-109.52%
Below sector avg (-51.02%)
ROIC-62.07%
Net Margin-1834.48%
Op. Margin-1906.37%

Safety

Debt / Equity
N/A
Current Ratio6.71
Interest CoverageN/A

Valuation

PE (TTM)
-1.64
Above sector avg (-1.98)
P/B Ratio1.94
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -1.6 -2.0
P/B 1.9 5.1
ROE % -109.5 -51.0
Net Margin % -1834.5 -150.2
Rev Growth 5Y % -17.9 9.3
D/E — 0.3

ETFs Holding This Stock

SPIT logo SPIT F/m Emerald Special Situations ETF
0.78% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.01% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 181.46% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -17.90% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 6.39 M Net Income (TTM) -117.26 M
ROE -109.52% ROA -68.58%
Gross Margin N/A Operating Margin -1906.37%
Net Margin -1834.48% Free Cash Flow (TTM) -79.08 M
ROIC -62.07% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6.71
Interest Coverage N/A Asset Turnover 0.04
Working Capital 83.59 M Tangible Book Value 99.03 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.64 Forward P/E N/A
P/B Ratio 1.94 P/S Ratio 30.07
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -41.15%
Market Cap 192.18 M Enterprise Value 168.03 M
Per Share
EPS (Diluted TTM) -12.48 Revenue / Share 0.44
FCF / Share -5.48 OCF / Share -5.45
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 8.10% FCF Conversion 67.44%
SBC-Adj. FCF N/A Growth Momentum 199.36

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 6.39 M 2.27 M — 0.0 14.07 M
Net Income -117.26 M -83.58 M -81.17 M -81.58 M -84.69 M
EPS (Diluted) -12.48 -9.37 -53.08 — —
Gross Profit — — — — —
Operating Income -121.86 M -91.91 M -84.53 M -83.00 M -84.03 M
EBITDA — — — — —
R&D Expenses 65.58 M 63.64 M 57.25 M 49.42 M 60.92 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — 0.0 961,000.0 764,000.0
Income Tax 637,000.0 141,000.0 27,000.0 -2,000.0 15,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 113.51 M 226.24 M 221.66 M 121.24 M 185.36 M
Total Liabilities 62.07 M 65.83 M 51.75 M 52.04 M 54.53 M
Shareholders' Equity 51.44 M 160.42 M 169.91 M 69.20 M 130.82 M
Total Debt — — — — —
Cash & Equivalents 21.82 M 55.64 M 166.15 M 51.95 M 79.64 M
Current Assets 82.37 M 131.53 M 172.73 M 87.49 M 134.75 M
Current Liabilities 11.94 M 14.96 M 19.48 M 21.03 M 11.43 M